Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer’s disease
Highlights • Treatment of APP/PS1 mice with antiTLR2 antibody for 7 months improves spatial learning. • Aβ plaque burden is reduced in antiTLR2 antibody-treated APP/PS1 mice. • These changes are associated with decreased microglial activation as indicated by reduced immunoreactivity for CD68. • Anti...
Gespeichert in:
Veröffentlicht in: | Brain, behavior, and immunity behavior, and immunity, 2016-11, Vol.58, p.191-200 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Treatment of APP/PS1 mice with antiTLR2 antibody for 7 months improves spatial learning. • Aβ plaque burden is reduced in antiTLR2 antibody-treated APP/PS1 mice. • These changes are associated with decreased microglial activation as indicated by reduced immunoreactivity for CD68. • Anti-TLR2 antibody treatment reduced GFAP immunoreactivity in hippocampus of APP/PS1 mice. |
---|---|
ISSN: | 0889-1591 1090-2139 |
DOI: | 10.1016/j.bbi.2016.07.143 |